重新评估子宫内膜异位症药物治疗的应答与失败:一项系统综述
该系统综述检索Medline和Embase,纳入58篇文章共125个治疗臂,评估子宫内膜异位症相关疼痛的药物治疗应答率。仅29篇文章报告了疼痛应答数据,无疼痛减轻的中位比例为11%-19%,治疗结束时仍有疼痛者为5%-59%,停药后随访疼痛复发者为17%-34%。作者认为报告患者相关结局的研究较少,许多女性从治疗中获益有限或间断。
要点
- 仅29/58篇文章报告了子宫内膜异位症相关疼痛对药物治疗的应答数据。
- 无疼痛减轻的中位比例为11%-19%,治疗结束时仍有疼痛者为5%-59%。
- 停药后随访疼痛复发的中位比例为17%-34%,中位研究时长2-24个月。
核心结论
- 针对子宫内膜异位症的药物治疗研究中,报告患者相关结局的研究较少,许多女性从治疗中仅获得有限或间断的获益。
研究设计与样本
- 系统综述,检索Medline和Embase,纳入58篇文章共125个治疗臂,研究对象为接受药物治疗子宫内膜异位症的女性。
主要发现
- 仅29篇文章报告了子宫内膜异位症相关疼痛症状对治疗的应答数据。
- 无疼痛减轻的女性中位比例为11%-19%。
- 治疗结束时仍有疼痛的女性比例为5%-59%。
- 停药后随访中疼痛症状复发的女性中位比例为17%-34%。
- 中位研究时长2-24个月,因不良事件或疗效不足的中位停药率为5%-16%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess patient response rates to medical therapies used to treat endometriosis-associated pain. DESIGN: A systematic review with the use of Medline and Embase. SETTING: Not applicable. PATIENT(S): Women receiving medical therapy to treat endometriosis. INTERVENTIONS(S): None. MAIN OUTCOME MEASURE(S): The proportions of patients who: experienced no reduction in endometriosis-associated pain symptoms; had pain symptoms remaining at the end of the treatment period; had pain recurrence after treatment cessation; experienced an increase or no change in disease score during the study; were satisfied with treatment; and discontinued therapy owing to adverse events or lack of efficacy. The change in pain symptom severity experienced during and after treatment, as measured on the visual analog scale, was also assessed. RESULT(S): In total, 58 articles describing 125 treatment arms met the inclusion criteria. Data for the response of endometriosis-associated pain symptoms to treatment were presented in only 29 articles. The median proportions of women with no reduction in pain were 11%-19%; at the end of treatment, 5%-59% had pain remaining; and after follow-up, 17%-34% had experienced recurrence of pain symptoms after treatment cessation. After median study durations of 2-24 months, the median discontinuation rates due to adverse events or lack of efficacy were 5%-16%. CONCLUSION(S): Few studies of medical therapies for endometriosis report outcomes that are relevant to patients, and many women gain only limited or intermittent benefit from treatment.
引用
- Becker CM, Gattrell WT, Gude K, et al. Reevaluating response and failure of medical treatment of endometriosis: a systematic review. Fertil Steril. 2017. PMID: 28668150. doi:10.1016/j.fertnstert.2017.05.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。